Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Applied DNA Sciences (APDN)
NASDAQ:APDN
Earnings Data
Report Date
May 08, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
―Last Year’s EPS
-1.8Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 13, 2025
|% Change Since: -5.88%
|Next Earnings Date:May 08, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook. While there were notable achievements in revenue growth, operational improvements, and strategic refocus on LineaRx, the exit from a business segment, workforce reduction, and ongoing financial challenges cast a shadow on the overall performance.Company Guidance
During the Applied DNA Sciences First Quarter Fiscal 2025 Financial Results call, significant guidance was provided regarding the company's strategic restructuring and financial performance. The company reported total revenues of $1.2 million for the first quarter, a notable increase from $891,000 in the same period of fiscal 2024. This growth stemmed from higher product revenue in the DNA tagging business and increased isotopic testing services revenue. However, the operating loss improved to $3 million from $3.8 million in the previous year, attributed to reduced selling, general, and administrative costs. A net loss of $2.7 million was recorded, compared to a $1.1 million loss in the prior year, due to an unrealized gain on the change in the fair value of warrants. The cash and cash equivalents as of December 31st stood at $9.3 million. The company also highlighted a strategic pivot to focus on its LineaRx subsidiary, exiting the DNA tagging segment and reducing the workforce by approximately 20%. This restructuring aims to optimize the cost structure and capitalize on the growing demand for synthetic DNA manufacturing, setting the stage for improved shareholder value and future growth opportunities.Increased Revenue
Total revenues for the first quarter of fiscal 2025 were $1.2 million, compared with $891,000 for the same period of fiscal 2024. This increase was driven by higher product revenue from DNA tagging and increased isotopic testing services.
Reduction in Operating Loss
Operating loss for the first quarter was $3 million, compared with $3.8 million in the prior year period, due to lower selling, general, and administrative costs.
GMP Site Certification
Certification of the GMP Site One facility has been completed, allowing for the production of DNA at scale.
Strategic Focus on LineaRx
The company has restructured to focus on the LineaRx subsidiary, aiming to capitalize on the growing demand for enzymatically produced DNA.
LineaRx Customer Growth
In fiscal 2024, LineaRx engaged over 25 customer projects, with expectations for multiple projects to enter the clinic in 2025.
Launch of New Product - Linea Donor DNA
Linea Donor DNA is a high-fidelity DNA form optimized for CRISPR gene editing, available for research use, with GMP availability targeted for later in the year.
---
APDN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
APDN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 13, 2025 | $0.17 | $0.17 | 0.00% |
| Dec 17, 2024 | $0.23 | $0.23 | 0.00% |
| Aug 08, 2024 | $0.35 | $0.36 | +2.86% |
| May 10, 2024 | $3.45 | $3.08 | -10.72% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Applied DNA Sciences (APDN) report earnings?
Applied DNA Sciences (APDN) is schdueled to report earning on May 08, 2025, TBA Not Confirmed.
What is Applied DNA Sciences (APDN) earnings time?
Applied DNA Sciences (APDN) earnings time is at May 08, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is APDN EPS forecast?
Currently, no data Available
---